Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Pancreatic Neoplasms HELP
Based on 30,763 articles published since 2009
|||| 45 

These are the 30763 published articles about Pancreatic Neoplasms that originated from Worldwide during 2009-2019.
 
+ Citations + Abstracts
Pages: 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · 11 · 12 · 13 · 14 · 15 · 16 · 17 · 18 · 19 · 20
151 Editorial Should Fear of Adverse Events Influence the Decision to Administer Preoperative Therapy to Patients with Pancreatic Cancer? 2018

Katz, Matthew H G. ·Pancreatic Surgical Service, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Mhgkatz@mdanderson.org. ·Ann Surg Oncol · Pubmed #29243201.

ABSTRACT: -- No abstract --

152 Editorial Prediction of pancreatic cancer risk and therapeutic response with next-generation sequencing. 2018

Kyrochristos, Ioannis D / Ziogas, Demosthenes E / Glantzounis, Georgios K / Roukos, Dimitrios H. ·Centre for Biosystems & Genome Network Medicine, Ioannina University, Ioannina, 45110, Greece. · Department of Surgery, Ioannina University Hospital, Ioannina, 45110, Greece. · Department of Surgery, 'G. Hatzikosta' General Hospital, Ioannina, 45001, Greece. · Department of Systems Biology, Biomedical Research Foundation of the Academy of Athens (BRFAA), Athens, 11527, Greece. ·Biomark Med · Pubmed #29235881.

ABSTRACT: -- No abstract --

153 Editorial The importance of a well-structured pancreatic screening program for familial and hereditary pancreatic cancer. 2018

Vasen, Hans F A. ·Department of Gastroenterology and Hepatology, Leiden University Medical Centre, Leiden, The Netherlands. hfavasen@stoet.nl. ·Fam Cancer · Pubmed #29204967.

ABSTRACT: -- No abstract --

154 Editorial A Symposium on Pancreatic Cancer: Time for a Paradigm Shift. An Overview and Personal Reflections. 2018

Cooperman, Avram M. ·The Pancreas, Biliary and Advanced Laparoscopy Center of New York, 305 Second Avenue, New York, NY 10003, USA. Electronic address: Avram.cooperman@gmail.com. ·Surg Clin North Am · Pubmed #29191283.

ABSTRACT: -- No abstract --

155 Editorial Challenges Staging Neuroendocrine Tumors of the Pancreas, Jejunum and Ileum, and Appendix. 2018

Nakakura, Eric K. ·Division of General Surgery, Section of Surgical Oncology/Hepatopancreaticobiliary Surgery, Department of Surgery and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA. Eric.Nakakura@ucsf.edu. ·Ann Surg Oncol · Pubmed #28779367.

ABSTRACT: -- No abstract --

156 Editorial 8th Edition of the AJCC Cancer Staging Manual: Pancreas and Hepatobiliary Cancers. 2018

Chun, Yun Shin / Pawlik, Timothy M / Vauthey, Jean-Nicolas. ·Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. jvauthey@mdanderson.org. ·Ann Surg Oncol · Pubmed #28752469.

ABSTRACT: -- No abstract --

157 Editorial Prognostic factors for gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): what's better? 2018

Milione, Massimo. ·Department of Pathology and Laboratory Medicine, 1st Division of Pathology, IRCCS Foundation National Cancer Institute, Milan, Italy. Massimo.milione@istitutotumori.mi.it. ·Endocrine · Pubmed #28417314.

ABSTRACT: -- No abstract --

158 Editorial Molecular landscape of pancreatic cancer: challenges and clinical implications. 2017

Kyrochristos, Ioannis D / Ziogas, Demosthenes E / Glantzounis, Georgios K / Roukos, Dimitrios H. ·Centre for Biosystems & Genome Network Medicine, Ioannina University, Ioannina 45110, Greece. · Department of Surgery, Ioannina University Hospital, Ioannina 45500, Greece. · Department of Surgery, 'G Hatzikosta' General Hospital, Ioannina 45001, Greece. · Biomedical Research Foundation of the Academy of Athens (BRFAA), Athens 11527, Greece. ·Future Oncol · Pubmed #29182377.

ABSTRACT: -- No abstract --

159 Editorial [Cystic tumors of the pancreas]. 2017

Hackert, T / Büchler, M W. ·Klinik für Allgemein‑, Viszeral- und Transplantationschirurgie, Universität Heidelberg, Im Neuenheimer Feld 110, 69120, Heidelberg, Deutschland. · Klinik für Allgemein‑, Viszeral- und Transplantationschirurgie, Universität Heidelberg, Im Neuenheimer Feld 110, 69120, Heidelberg, Deutschland. markus_buechler@med.uni-heidelberg.de. ·Chirurg · Pubmed #29124330.

ABSTRACT: -- No abstract --

160 Editorial Enteric Glia: The Origin of Duodenal Gastrinomas? 2017

Gulbransen, Brian D. ·Neuroscience Program and Department of Physiology, Michigan State University, East Lansing, Michigan. Electronic address: gulbrans@msu.edu. ·Gastroenterology · Pubmed #29100851.

ABSTRACT: -- No abstract --

161 Editorial A plea for more practical and clinically applicable criteria defining type 3c diabetes. 2017

Roeyen, Geert / De Block, Christophe. ·Department of HPB, Endocrine and Transplantation Surgery, Antwerp University Hospital, Belgium. Electronic address: Geert.roeyen@uza.be. · Department of Endocrinology, Diabetology and Metabolic Diseases, Antwerp University Hospital, Belgium. ·Pancreatology · Pubmed #29050930.

ABSTRACT: -- No abstract --

162 Editorial Endoscopic Ultrasound-Guided Pancreatic Cyst Ablation: More Peril Than Promise? 2017

Yachimski, Patrick / Varadarajulu, Shyam. ·Division of Gastroenterology, Hepatology & Nutrition, Vanderbilt University Medical Center, Nashville, Tennessee. · Center for Interventional Endoscopy, Florida Hospital Orlando, Orlando, Florida. ·Gastroenterology · Pubmed #28987419.

ABSTRACT: -- No abstract --

163 Editorial "Revisions of the International Consensus Fukuoka Guidelines for the Management of IPMN of the Pancreas": Progress for twelve years. 2017

Takaori, Kyoichi. ·Department of Surgery, Kyoto University Graduate School of Medicine, 54 Kawara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan. Electronic address: takaori@kuhp.kyoto-u.ac.jp. ·Pancreatology · Pubmed #28864411.

ABSTRACT: -- No abstract --

164 Editorial Pancreatic cyst ablation: why are we not doing more of these procedures? 2017

DeWitt, John M. ·Department of Gastroenterology and Hepatology, Indiana University Health Medical Center, Indianapolis, Indiana, United States. ·Endoscopy · Pubmed #28850976.

ABSTRACT: -- No abstract --

165 Editorial Germline Testing for Individuals With Pancreatic Cancer: The Benefits and Challenges to Casting a Wider Net. 2017

Yurgelun, Matthew B. ·Matthew B. Yurgelun, Dana-Farber Cancer Institute; Brigham & Women's Hospital; and Harvard Medical School, Boston, MA. ·J Clin Oncol · Pubmed #28834438.

ABSTRACT: -- No abstract --

166 Editorial Biomarkers, imaging and multifocality in intraductal papillary mucinous neoplasms: relevant for decision making? 2017

Ansari, Daniel / Aronsson, Linus / Andersson, Roland. ·Department of Surgery, Clinical Sciences Lund, Lund University, Skåne University Hospital, Lund, Sweden. ·Future Oncol · Pubmed #28831817.

ABSTRACT: -- No abstract --

167 Editorial Road to perdition: Zeb1-dependent and -independent ways to metastasis. 2017

Brabletz, Simone / Brabletz, Thomas / Stemmler, Marc P. ·a Department of Experimental Medicine I , Nikolaus-Fiebiger Center for Molecular Medicine, Friedrich-Alexander University of Erlangen-Nürnberg , Erlangen , Germany. ·Cell Cycle · Pubmed #28820324.

ABSTRACT: -- No abstract --

168 Editorial Peritoneal Metastases from Gastroenteropancreatic Neuroendocrine Tumors. 2017

Frilling, Andrea / Clift, Ashley K. ·Department of Surgery and Cancer, Imperial College London, London, UK. a.frilling@imperial.ac.uk. · Department of Surgery and Cancer, Imperial College London, London, UK. ·Ann Surg Oncol · Pubmed #28815440.

ABSTRACT: -- No abstract --

169 Editorial Editorial: Stopping Pancreatic Cyst Surveillance? 2017

Farrell, James J. ·Yale Pancreatic Disease Program, Interventional Endoscopy, Yale School of Medicine, New Haven, CT, USA. ·Am J Gastroenterol · Pubmed #28725064.

ABSTRACT: The management of patients with pancreatic cysts, especially presumed branch duct intraductal papillary mucinous neoplasms (BD-IPMNs), remains a challenge. BD-IPMNs carry a very low risk of malignancy and occur in predominantly older individuals who often die from causes not related to their pancreatic disease. The specific decision to stop surveillance of presumed low risk BD-IPMNs (those without either worrisome features (WF) or high risk stigmata (HRS)) is controversial, and needs to balance the real risk of malignancy or developing malignancy and IPMN-related mortality, with the patient's life expectancy, quality of life expectations, and mortality from non-pancreatic-related causes. With improved life expectancy, improved survival from non-pancreatic malignancies, rising health costs, and growing detection of ever smaller presumed BD-IPMNs, this issue is becoming ever more critical.

170 Editorial Pancreatic cancer screening. 2017

Soldan, Mônica. ·- Federal University of Rio de Janeiro, Clementino Fraga Filho University Hospital, Gastroenterology Service, Rio de Janeiro, RJ, Brazil. · - São Vicente de Paulo Hospital, Endoscopy Service, Rio de Janeiro, RJ, Brazil. ·Rev Col Bras Cir · Pubmed #28658327.

ABSTRACT: -- No abstract --

171 Editorial Which Is Crucial, Strengthen the Foundation or Building the Dream House? 2017

Isayama, Hiroyuki / Nakai, Yousuke / Fujisawa, Toshio. ·Department of Gastroenterology, Graduate School of Medicine, Juntendo University, Tokyo, Japan. · Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. ·Gut Liver · Pubmed #28647955.

ABSTRACT: -- No abstract --

172 Editorial Role of surgery in pancreatic cancer. 2017

Buanes, Trond A. ·Trond A Buanes, Department of Hepato-Pancreatico-Biliary Surgery, Oslo University Hospital, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Pb 4956 N-0424 Oslo, Norway. ·World J Gastroenterol · Pubmed #28638216.

ABSTRACT: Treatment of pancreatic cancer is multimodal and surgery is an essential part, mandatory for curative potential. Also chemotherapy is essential, and serious postoperative complications or rapid disease progression may preclude completion of multimodal treatment. The sequence of treatment interventions has therefore become an important concern, and numerous ongoing randomized controlled trials compare clinical outcome after upfront surgery and neoadjuvant treatment with subsequent resection. In previous years, borderline resectable and locally advanced pancreatic cancer was most often considered unresectable. More effective chemotherapy together with the latest improvements in surgical expertise has resulted in extended operations, pushing the borders of resectability. Multivisceral resections with or without resection of major mesenteric vessels are now performed in numerous patients, resulting in better outcome, recorded as overall survival and/or patient reported outcome. But postoperative morbidity increases concurrently, and clinical benefit must be carefully evaluated against risk of potential harm, associated with new comprehensive multimodal treatment sequences. Even though cost/utility analyses are deficient, extended surgery has resulted in significantly longer and better life for many patients with no other treatment alternative. Improved selection of patients to surgery and/or chemotherapy will in the near future be possible, based on better tumor biology insight. Clinically available biomarkers enabling personalized treatment are forthcoming, but these options are still limited. The importance of surgical resection for each patient's prognosis is presently increasing, justifying sustained expansion of the surgical treatment modality.

173 Editorial Radiofrequency ablation for intraductal extension of ampullary neoplasms: Are we ready to feel the burn? 2017

Watson, Rabindra R / Muthusamy, V Raman. ·Vatche and Tamar Manoukian Division of Digestive Diseases, David Geffen School of Medicine at UCLA, Los Angeles, California, USA. ·Gastrointest Endosc · Pubmed #28610856.

ABSTRACT: -- No abstract --

174 Editorial Pancreatic Cysts: Controversies, Advances, Diagnoses, and Therapies. 2017

Barkin, Jodie A / Barkin, Jamie S. ·From the Division of Gastroenterology, Department of Medicine, University of Miami Leonard M. Miller School of Medicine, Miami, FL. ·Pancreas · Pubmed #28609359.

ABSTRACT: Pancreatic cysts are commonly found on cross-sectional imaging. The question arises in determining which lesions are premalignant or malignant and may require further testing, intervention, or follow-up. In pancreatic cysts without obvious malignancy on imaging, we approach them using the Four "S" Criteria. These are (1) symptoms that may be originating from the pancreatic cyst; (2) size of the cyst 2 cm or larger and/or main pancreatic duct greater than 5 mm; (3) survival of the patient, based on comorbidity index to determine surgical fitness; and then endoscopic ultrasound with fine needle aspiration (FNA) recommended to determine (4) solid component presence in the cyst, namely, nodule or thick walls, as well as to perform FNA to obtain cyst content. Current cyst fluid analysis options include use of cytology to determine presence of malignancy and carcinoembryonic antigen and fluid genetics to identify potentially premalignant lesions. The aims of this article are to explore current management guidelines for pancreatic cysts, present a comprehensive approach to pancreatic cysts, and explain the advantages and disadvantages of each option for evaluation of pancreatic cysts including endoscopic ultrasound with FNA with cyst fluid analysis using an evidence-based approach.

175 Editorial Accelerating progress in the fight against pancreatic cancer Proceedings of the 2017 Leo and Anne Albert Symposium for Pancreatic Cancer Research. 2017

Melstrom, Laleh G / Singh, Gagandeep / Fong, Yuman. ·Assistant Professor of Surgery and Experimental Therapeutics, City of Hope Medical Center. · Clinical Professor of Surgery, City of Hope Medical Center. · Professor and Sangiacomo Chair and Chairman Department of Surgery, City of Hope Medical Center. ·J Surg Oncol · Pubmed #28608945.

ABSTRACT: -- No abstract --

Back · Next